Stocks To Buy Now

Blog


DGE Hosts Artificial Intelligence For Life Sciences Compliance Conference, Philadelphia

DGE invites professionals and executives of life science companies catering to risk management, data privacy, analytics, and compliance, for the Artificial Intelligence for Life Sciences Compliance conference. The event will be held on June 3-4, 2024, in Philadelphia. The main agenda of the conference is to discuss methods of modernizing compliance, risk management, and protecting organizations in the age of AI.

The event is hosted by Dynamic Global Events (“DGE”), a Life Science leader in organizing B2B events. The global event company caters to the dynamic informational and networking needs of the Pharmaceutical, Biotechnology, Healthcare, Medical Devices, and allied industries.

DGE offers a robust platform for networking where attendees can meet and collaborate with industries and entrepreneurs from the life science spectrum. They connect with industry leaders during the speaker sessions and discussion panels where experts delve into in-depth discussions on pivotal topics. Peers will exchange their ideas on the risks and strategies involved in AI implementation.

Important topics of discussion:

  • Identification of areas of AI and machine learning implementation in life science companies
  • Understand the latest regulatory policies
  • Leverage AI to update risk management and compliance monitoring
  • Discover the data privacy risks associated with AI
  • Create a framework of ethics and compliance
  • Strengthen predictive analytics with AI

The DGE conference in Philadelphia is a well-curated event that focuses on a targeted audience of like-minded professionals seeking industry connections and engagement. With global leaders making their presence at the event, newcomers and industry professionals can leverage the opportunity to interact and build long-term connections. The experts offer their invaluable insights and ideas to an interactive audience looking for answers to their queries on compliance and risk management with AI.

To know more, please visit https://ibn.fm/io9H4.

From Our Blog

Nutriband Inc. (NASDAQ: NTRB) Pioneers Innovative Approach to Opioid Crisis with Game-Changing Transdermal Patch

May 13, 2025

As the opioid crisis continues to challenge public health systems, the need for innovative solutions has become increasingly apparent. Rather than relying solely on restrictive measures, companies such as Nutriband (NASDAQ: NTRB) are exploring technological advancements to mitigate abuse while ensuring patient access to necessary medications. Nutriband’s development of AVERSA(TM) Fentanyl, an abuse-deterrent transdermal patch, exemplifies […]

Rotate your device 90° to view site.